NCT02954081View on ClinicalTrials.gov

APremilast After FumaRic Acid Ester Treatment

CompletedOBSERVATIONAL

Enrollment

687

Participants

Timeline

Start Date

January 26, 2017

Primary Completion Date

August 15, 2022

Study Completion Date

August 15, 2022

Conditions

Psoriasis

Interventions

DRUG

Phase I: Fumaric acid esters. Phase II: Apremilast

Apremilast

Trial Locations (1)

20354

Site, Hamburg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY